Skip to product information
1 of 3

Pure Encapsulations

DIMPRO® 100

DIMPRO® 100

Regular price $105.45 USD
Regular price Sale price $105.45 USD
Sale Sold out

DIMPRO® 100 contains BioResponse DIM® (diindolylmethane complex). Diindolylmethane is a metabolite of indole-3-carbinol (I3C). Both are metabolites of glucosinolates found naturally in cruciferous vegetables like broccoli, kale and Brussels sprouts. Upon contact with gastric acid in the stomach, I3C is converted to a number of active compounds, predominantly diindolylmethane. Research indicates that diindolylmethane supports healthy cell cycle function and signal transduction to maintain breast, cervical and prostate cell health.1,2,3 In a double-blind, randomized clinical trial, BioResponse DIM® revealed potential support for maintaining the function of healthy breast cells.4 Another randomized placebo-controlled crossover trial found that it promoted statistically significant breast comfort.5 Furthermore, an additional doubleblind, randomized clinical trial with 52 women found that BioResponse DIM® supported cervical cell health.6 Diindolylmethane in its pure form is highly insoluble. Patented, microencapsulated BioResponse DIM® has been specially developed for enhanced solubility and absorption.7 This form may be more supportive than I3C in cases of low gastric acidity. 

Serving Size: 1 capsule

Servings Per Container: 120

Recommended Subscription: Delivery every 120 days

Benefits:

  • Potential support for maintaining the function of healthy breast cells and breast comfort
  • Promotes cervical and prostate cell health
  • Supports healthy cell cycle function and signal transduction
  • Offers BioResponse DIM® , specially developed for enhanced absorption
  • Formulated with ingredients naturally found in vegetables like broccoli, kale and Brussels sprouts
  • Made with vegan ingredients

Recommendation: Take 1-3 capsules as directed by your provider.

More Information

1. Ahmad A, et al. Int J Cancer. 2011 Oct 1;129(7):1781-91.
2. Zeligs MA, et al. JAJA. 2005. 8(1); 10-20.
3. Kong D, et al. Cancer Res. 2007 Apr 1;67(7):3310-9.
4. Dalessandri KM, et al. Nutr Cancer.2004;50(2):161-7.
5. Zeligs MA, et al. JAJA. 2005. 8(1); 10-20.
6. Del Priore G, et al. Gynecol Oncol. 2010 Mar;116(3):464-7.
7. Anderton MJ, et al. Drug Metab Dispos. 2004
Jun;32(6):632-8.

Supplement Fact Sheet

PDF
View full details